gemeprost and isosorbide-5-mononitrate

gemeprost has been researched along with isosorbide-5-mononitrate* in 3 studies

Trials

3 trial(s) available for gemeprost and isosorbide-5-mononitrate

ArticleYear
Second trimester abortion using isosorbide mononitrate in addition to gemeprost compared with gemeprost alone: a double-blind randomized, placebo-controlled multicenter trial.
    American journal of obstetrics and gynecology, 2005, Volume: 192, Issue:3

    We aimed to determine whether second-trimester abortion using isosorbide mononitrate (IMN) in addition to gemeprost is more effective and reduces side effects compared with gemeprost alone.. Eighty women who were age 13 to 23 weeks' gestation were randomly assigned to receive per vaginam either IMN 40 mg (group 1, 40 women) or placebo (group 2, 40 women) in addition to gemeprost 1 mg up to 3 times daily 3 hours apart for 2 days. Analysis of variance, a chi 2 test, and a multivariate analysis were performed.. Of the 72 women analyzed, 68% (group 1) and 38% (group 2) underwent abortion within day 1 (P < .05). However, group 1 was associated with more headache (18% of women) 3 hours after induction compared to group 2 (0% of women, P = .038).. IMN in addition to gemeprost is effective for second-trimester abortion, but is associated with more headache compared with gemeprost alone.

    Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Administration, Intravaginal; Alprostadil; Analysis of Variance; Female; Humans; Isosorbide Dinitrate; Multivariate Analysis; Nitric Oxide Donors; Pregnancy; Pregnancy Trimester, Second

2005
Randomised trial of nitric oxide donor versus prostaglandin for cervical ripening before first-trimester termination of pregnancy.
    Lancet (London, England), 1998, Oct-03, Volume: 352, Issue:9134

    Vaginal administration of the nitric oxide donor isosorbide mononitrate can induce effective ripening of the human cervix. We investigated whether this drug is associated with fewer side-effects than prostaglandins when used to ripen the cervix before first-trimester surgical termination of pregnancy, and assessed whether the extent of cervical ripening it induces is clinically sufficient.. 66 primigravid women scheduled for surgical termination were assigned to receive before surgery, per vaginam, isosorbide mononitrate 40 mg or 80 mg, or the prostaglandin analogue gemeprost 1 mg. The primary measured outcome was onset of new symptoms before termination of pregnancy.. More women remained symptom-free after isosorbide mononitrate than after gemeprost (28/44 [64%] vs 3/22 [14%], p<0.005). Pretreatment with gemeprost resulted in abdominal pain in 73% of women and vaginal bleeding in 32% compared with 3% and 0%, respectively, after isosorbide mononitrate, whereas, more women developed headache after isosorbide mononitrate (27%) than after gemeprost (0%). Cervical resistance and measured intraoperative blood loss were lowest after pretreatment with gemeprost. The measured cervical resistance and intraoperative blood loss with either dose of isosorbide mononitrate did not differ from those in a comparison group of 22 parous women not in the randomised trial.. Pretreatment with isosorbide mononitrate to ripen the cervix before first-trimester termination of pregnancy is associated with fewer side-effects than gemeprost treatment and adequately decreases cervical resistance. Isosorbide mononitrate could be used as an alternative to gemeprost for this indication.

    Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Alprostadil; Cervical Ripening; Dose-Response Relationship, Drug; Female; Humans; Isosorbide Dinitrate; Nitric Oxide Donors; Pregnancy; Pregnancy Trimester, First

1998
Nitric oxide donors induce ripening of the human uterine cervix: a randomised controlled trial.
    British journal of obstetrics and gynaecology, 1997, Volume: 104, Issue:9

    To determine whether nitric oxide donors can induce cervical ripening before surgical termination of pregnancy in the first trimester.. Prospective, randomised controlled trial.. Department of Obstetrics and Gynaecology, Royal Infirmary, Glasgow.. Forty-eight primigravid women undergoing surgical termination of pregnancy before 12 weeks of gestation.. The women were randomised to receive per vaginam before surgery either the nitric oxide donor isosorbide mononitrate, the nitric oxide donor glyceryl trinitrate, the prostaglandin analogue gemeprost, or no treatment.. The cumulative force required to dilate the cervix to 8 mm was measured objectively and the cervical diameter before surgical dilatation was recorded.. Following isosorbide mononitrate or gemeprost, a lower cumulative force was required to dilate the cervix to 8 mm and a higher cervical diameter before dilatation was recorded. Pretreatment with glyceryl trinitrate reduced the cumulative force required to dilate the cervix but had no effect on cervical diameter.. Like the prostaglandin analogue gemeprost, the nitric oxide donors isosorbide mononitrate and glyceryl trinitrate can effect cervical ripening. Nitric oxide donors may provide an alternative to prostaglandins for cervical ripening before surgical procedures in the first trimester.

    Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Administration, Intravaginal; Adult; Alprostadil; Cervix Uteri; Female; Humans; Isosorbide Dinitrate; Nitric Oxide; Pregnancy; Pregnancy Trimester, First; Prospective Studies

1997